Accel Diagnostics, LLC

Accel Diagnostics (ADx) is a health care startup dedicated to developing and manufacturing blood diagnostic tests and laboratory analyzers. Founded in 2012 in the United States, the company focuses on creating proprietary point-of-care diagnostic assays for the diagnosis, monitoring, and management of various medical conditions. ADx's technology enables patients and healthcare providers to conduct lab-quality medical diagnostic tests anytime and anywhere, transforming the patient blood testing paradigm from lab-centered to near-patient. This technology brings significant advantages in terms of simplicity, time to result, care delivery, and cost over current standard lab-based diagnostics. During the COVID-19 pandemic, Accel Diagnostics took an active role by operating the ADX Diagnostic Lab to provide high-quality COVID testing in Houston, TX. The company received a Convertible Note investment from Innovation Works on 04 May 2016. Accel Diagnostics' commitment to revolutionizing medical diagnostics and its proactive response to the COVID-19 crisis demonstrates its potential to create a positive impact on the healthcare industry. With its innovative technology and dedication to improving patient care, ADx presents an appealing investment opportunity for venture capitalists looking to support groundbreaking advancements in health technology.